Siegfried Biologics

Siegfried is a leading global Contract Development and Manufacturing Organization (CDMO) headquartered in Switzerland, specializing in the development and production of both drug substances and drug products. The company's biologics division, often referred to as Siegfried Biologics, provides comprehensive services for monoclonal antibodies, recombinant proteins, and advanced therapy medicinal products (ATMPs). With a strategic focus on high-growth areas, Siegfried recently expanded its footprint through the acquisition of a biologics manufacturing site in Grafton, Wisconsin, and a majority stake in the gene therapy specialist DINAMIQS. Their service offering spans from pharmaceutical development and clinical trial material production to commercial-scale manufacturing and aseptic filling. Siegfried maintains a robust global network of sites across Europe, North America, and Asia, serving a diverse range of pharmaceutical and biotech clients.